PDS Planning’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $642K | Buy |
5,790
+592
| +11% | +$65.6K | 0.05% | 194 |
|
|
2025
Q1 | $582K | Buy |
5,198
+528
| +11% | +$59.2K | 0.05% | 189 |
|
|
2024
Q4 | $431K | Buy |
4,670
+170
| +4% | +$15.7K | 0.04% | 216 |
|
|
2024
Q3 | $377K | Buy |
4,500
+433
| +11% | +$36.3K | 0.03% | 246 |
|
|
2024
Q2 | $279K | Sell |
4,067
-695
| -15% | -$47.7K | 0.03% | 273 |
|
|
2024
Q1 | $349K | Buy |
4,762
+336
| +8% | +$24.6K | 0.04% | 220 |
|
|
2023
Q4 | $359K | Buy |
4,426
+182
| +4% | +$14.7K | 0.04% | 202 |
|
|
2023
Q3 | $318K | Sell |
4,244
-43
| -1% | -$3.22K | 0.04% | 205 |
|
|
2023
Q2 | $330K | Buy |
4,287
+84
| +2% | +$6.47K | 0.04% | 195 |
|
|
2023
Q1 | $349K | Buy |
4,203
+1,590
| +61% | +$132K | 0.05% | 169 |
|
|
2022
Q4 | $224K | Buy |
+2,613
| New | +$224K | 0.04% | 183 |
|